Company profile
Parabilis Medicines, Inc.
NASDAQ:PBLSBiotechnology: Pharmaceutical Preparations
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05919264 | phase1_2 | recruiting | 2023-05-23 | 2027-04-01 | Parabilis Medicines, Inc. | FOG-001 in Locally Advanced or Metastatic Solid Tumors |
FDA applications (0)
No records yet.